We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Serum Zn Status of Patients With Cystic Fibrosis at Diagnosis and One Year Later, Compared to a Healthy Control Group

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00221559
Recruitment Status : Completed
First Posted : September 22, 2005
Last Update Posted : May 9, 2006
Sponsor:
Collaborator:
Information provided by:

Study Description
Brief Summary:
Serum Zn status of patients with cystic fibrosis at diagnosis and one year later, compared to a healthy control group

Condition or disease Intervention/treatment
Cystic Fibrosis Procedure: Blood sampling for determination of serum Zn

Detailed Description:
Serum Zn status of patients with cystic fibrosis at diagnosis and one year later, compared to a healthy control group

Study Design

Study Type : Observational
Estimated Enrollment : 0 participants
Observational Model: Defined Population
Primary Purpose: Screening
Time Perspective: Cross-Sectional
Time Perspective: Prospective
Official Title: Serum Zn Status of Patients With Cystic Fibrosis at Diagnosis and One Year Later, Compared to a Healthy Control Group
Study Start Date : September 2004

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Cystic Fibrosis
U.S. FDA Resources

Groups and Cohorts


Outcome Measures

Eligibility Criteria

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   Child, Adult, Senior
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Diagnosis of cystic fibrosis

Exclusion Criteria:

Contacts and Locations

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00221559


Locations
Belgium
University Hospital Ghent
Ghent, Belgium, 9000
Sponsors and Collaborators
University Hospital, Ghent
Scientific research fund Bruges
Investigators
Principal Investigator: Stephanie Van Biervliet, MD University Hospital, Ghent
More Information

Additional Information:
Publications:
ClinicalTrials.gov Identifier: NCT00221559     History of Changes
Other Study ID Numbers: UZGhent 001
First Posted: September 22, 2005    Key Record Dates
Last Update Posted: May 9, 2006
Last Verified: May 2006

Additional relevant MeSH terms:
Fibrosis
Cystic Fibrosis
Pathologic Processes
Pancreatic Diseases
Digestive System Diseases
Lung Diseases
Respiratory Tract Diseases
Genetic Diseases, Inborn
Infant, Newborn, Diseases